# The Efficacy and Safety of Liposomal Bupivacaine for Rhomboid Intercostal Nerve Block in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery

> **NCT07441902** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 134 (estimated)

## Conditions studied

- Video-assisted Thoracoscopic Surgery (VATS)
- Pain Management
- Liposomal Bupivacaine
- Rhomboid Intercostal Block

## Interventions

- **DRUG:** Bupivacaine hydrochloride
- **DRUG:** Liposomal bupivacaine plus bupivacaine

## Key facts

- **NCT ID:** NCT07441902
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-02
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07441902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07441902, "The Efficacy and Safety of Liposomal Bupivacaine for Rhomboid Intercostal Nerve Block in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07441902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*